Literature DB >> 8855869

Case-control study of venous thromboembolism risk in users of hormone replacement therapy.

E Daly, M P Vessey, R Painter, M M Hawkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8855869     DOI： 10.1016/S0140-6736(96)24041-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Assessment of the risk for venous thromboembolism among users of hormone replacement therapy.

Authors:  E Oger; P Y Scarabin
Journal:  Drugs Aging       Date:  1999-01       Impact factor: 3.923

Review 2.  The adverse effects of hormone replacement therapy.

Authors:  A Tavani; C La Vecchia
Journal:  Drugs Aging       Date:  1999-05       Impact factor: 3.923

3.  Safety profile of raloxifene as used in general practice in England: results of a prescription-event monitoring study.

Authors:  Deborah Layton; Andrea Clarke; Lynda V Wilton; Saad A W Shakir
Journal:  Osteoporos Int       Date:  2004-08-07       Impact factor: 4.507

4.  The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial.

Authors:  Madge R Vickers; Jeannett Martin; Tom W Meade
Journal:  BMC Womens Health       Date:  2007-02-26       Impact factor: 2.809

5.  Clinical and laboratory manifestations of the prothrombin gene mutation in women of reproductive age.

Authors:  A P Momot; M G Nikolaeva; N N Yasafova; M S Zainulina; K A Momot; I A Taranenko
Journal:  J Blood Med       Date:  2019-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.